III. Example 2:
Aspirin–Heart Bypass
Study
Data source: Gavaghan et al., 1991
Subjects: 214 patients received up
to 6 coronary bypass grafts.
Randomly assigned to treatment
group:
ASPIRIN¼
1 if daily aspirin
0 if daily placebo
Response (D): Occlusion of a bypass
graft 1 year later
D¼
1 if blocked
0 if unblocked
Additional covariates:
AGE (in years)
GENDER (1¼male, 2¼female)
WEIGHT (in kilograms)
HEIGHT (in centimeters)
Correlation structures to consider:
Exchangeable
Independent
Model 1:interaction model
Interaction terms between ASPIRIN
and the other four covariates
included.
logit PðD¼ 1 jXÞ
¼b 0 þb 1 ASPIRINþb 2 AGE
þb 3 GENDERþb 4 WEIGHT
þb 5 HEIGHTþb 6 ASPIRINAGE
þb 7 ASPIRINGENDER
þb 8 ASPIRINWEIGHT
þb 9 ASPIRINHEIGHT
The next example uses data from a study in
Sydney, Australia, which examined the efficacy
of aspirin for prevention of thrombotic graft
occlusion after coronary bypass grafting
(Gavaghan et al., 1991). Patients (K¼214)
were given a variable number of artery
bypasses (up to six) in a single operation, and
randomly assigned to take either aspirin (ASPI-
RIN¼1) or a placebo (ASPIRIN¼0) every
day. One year later, angiograms were per-
formed to check each bypass for occlusion
(the outcome), which was classified as blocked
(D¼1) or unblocked (D¼0). Additional cov-
ariates include AGE (in years), GENDER (1¼
male, 2¼female), WEIGHT (in kilograms),
and HEIGHT (in centimeters).
In this study, there is no meaningful distinc-
tion between artery bypass 1, artery bypass 2,
or artery bypass 3 in the same subject. Since
the order of responses within a cluster is arbi-
trary, we may consider using either the exchan-
geable or independent correlation structure.
Other correlation structures make use of an
inherent order for the within-cluster responses
(e.g., monthly measurements), so they are not
appropriate here.
The first model considered (Model 1) allows for
interaction between ASPIRIN and each of the
other four covariates. The model can be stated
as shown on the left.
Presentation: III. Example 2: Aspirin–Heart Bypass Study 551